Publications
Selected publications
Can B cell-deficient patients rely on COVID-19 vaccine-induced T-cell immunity?.
Shree T. Br J Haematol. 2022 Jun;197(6):659-661. doi: 10.1111/bjh.18210. Epub 2022 Apr 25. PubMed PMID: 35412649; PubMed Central PMCID: PMC9111762.
Intratumoral immunotherapy relies on B and T cell collaboration.
Sagiv-Barfi I, Czerwinski DK, Shree T, Lohmeyer JJK, Levy R. Sci Immunol. 2022 May 27;7(71):eabn5859. doi: 10.1126/sciimmunol.abn5859. Epub 2022 May 27. PubMed PMID: 35622903; PubMed Central PMCID: PMC9254330.
CD20-Targeted Therapy Ablates De Novo Antibody Response to Vaccination but Spares Preestablished Immunity.
Shree T, Shankar V, Lohmeyer JJK, Czerwinski DK, Schroers-Martin JG, Rodriguez GM, Beygi S, Kanegai AM, Corbelli KS, Gabriel E, Kurtz DM, Khodadoust MS, Gupta NK, Maeda LS, Advani RH, Alizadeh AA, Levy R. Blood Cancer Discov. 2022 Mar 1;3(2):95-102. doi: 10.1158/2643-3230.BCD-21-0222. PubMed PMID: 35015688.
Single-cell analysis can define distinct evolution of tumor sites in follicular lymphoma.
Haebe S*, Shree T*, Sathe A, Day G, Czerwinski DK, Grimes SM, Lee H, Binkley MS, Long SR, Martin B, Ji HP, Levy R. Blood. 2021 May 27;137(21):2869-2880. doi: 10.1182/blood.2020009855. PubMed PMID: 33728464; PubMed Central PMCID: PMC8160505. *Equal contribution.
Impaired Immune Health in Survivors of Diffuse Large B-Cell Lymphoma.
Shree T, Li Q, Glaser SL, Brunson A, Maecker HT, Haile RW, Levy R, Keegan THM. J Clin Oncol. 2020 May 20;38(15):1664-1675. doi: 10.1200/JCO.19.01937. Epub 2020 Feb 21. PubMed PMID: 32083991; PubMed Central PMCID: PMC7238489.
Macrophages and cathepsin proteases blunt chemotherapeutic response in breast cancer.
Shree T, Olson OC, Elie BT, Kester JC, Garfall AL, Simpson K, Bell-McGuinn KM, Zabor EC, Brogi E, Joyce JA. Genes Dev. 2011 Dec 1;25(23):2465-79. doi: 10.1101/gad.180331.111. PubMed PMID: 22156207; PubMed Central PMCID: PMC3243057.